Saura C, Modi S, Krop I, Park YH, et al. Trastuzumab Deruxtecan in Previously Treated Patients With HER2-Positive Metastatic Breast Cancer: Updated Survival Results From a Phase 2 Trial (DESTINY-Breast01). Ann Oncol 2023 Dec 11:S0923-7534(23)05108-6. doi: 10.1016/j.annonc.2023.
PMID: 38092229